Johnson & Johnson SPINE & OTHER — Percent Change (as a percent) increased by 1066.7% to 3.5% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 132.4%, from -10.8% to 3.5%. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates segment expansion and market share gains, whereas a negative percentage suggests a contraction in demand or loss of competitive standing.
This metric measures the period-over-period percentage growth or decline in net sales for the spine, sports medicine, an...
Comparable to organic or reported segment growth rates reported by diversified medical device manufacturers.
jnj_segment_spine_sports_other_percent_change_as_a_percent| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 55.3% | -5.3% | 0.6% | -6.8% | 0.3% | 2.4% | 5.8% | 0.2% | 3.2% | -3.1% | -1.9% | -10.8% | -2.1% | 0.3% | 3.5% |
| QoQ Change | — | -109.6% | +111.3% | <-999% | +104.4% | +700.0% | +141.7% | -96.6% | >999% | -196.9% | +38.7% | -468.4% | +80.6% | +114.3% | >999% |
| YoY Change | — | — | — | -112.3% | +105.7% | +300.0% | +185.3% | -33.3% | +33.3% | -153.4% | <-999% | -437.5% | +32.3% | +115.8% | +132.4% |